An automatic implantable cardiac defibrillator (AICD) is a device that is implanted in the chest to constantly monitor and, if necessary, correct episodes of arrhythmia. While the longevity of the average AICD patient has increased to 10 years after implantation, only 5% of implants functioned for seven years, and this mismatch poses a significant and ever growing clinical and economic burden. Moreover, there are now efforts to “piggyback” devices on AICDs and BVPs for additional functionality, all of which require more power. An innovative approach towards generating power for AICDs is to harness the energy of the heart by embedding energy generators in AICD leads. The cardiovascular system as a source generator is appealing due to its ability to continuously deliver mechanical energy as long as the patient is alive. Herein a device incorporating nanostructured piezoelectrics was developed as a means to harvest the energy of heart. The generator system integrates inorganic piezoelectric nanomaterials, including aligned arrays of nanowires of crystalline zinc oxide (ZnO), with elastomeric substrates. The design combines several innovative structural configurations including a “wavy” flexible electrode and a layout where the nanowires are near or on the neutral mechanical plane. A wet synthetic strategy to reliably prepare piezoelectric ZnO nanostructures directly onto the devices was also developed and optimized to produce nanowires with high densities, large aspect ratios and high orientation. The elastomeric support permits direct integration within AICD leads and is small and flexible enough to not add resistance in systole. The flexible devices were integrated into a testbed mimicking the input a failing right ventricle and the results demonstrate progress towards energy harvesting from the cardiovascular system. A model was developed to gain insight as to how to structure the nanowire array within the latitude of the synthesis to boost the energy production. To further improve the output, the nanowires were passivated with dipolar molecules to change their resistivities and the barrier height of the Schottky contact. A novel low photon energy photoelectron spectroscopy tool was developed to measure the effects of the molecules on the individual nanowire properties. This concept of using nanostructured piezoelectrics as a means to convert the energy of the body may in the coming years represent a paradigm shift from battery dependant AICD modules to completely autonomous functional systems. / text

Thesis (M.S.)--California Polytechnic State University, 2009. / Title from PDF title page; viewed on March 11, 2009. "February 2009." "In partial fulfillment of the requirements for the degree [of] Master of Science in Engineering with Specializations in Biomedical Engineering." "Presented to the faculty of California Polytechnic State University, San Luis Obispo." Major professor: Lanny Griffin, Ph.D. Includes bibliographical references (p. 42). Also available on microfiche.

Thesis (Ph. D.)--University of Hong Kong, 2008. / Includes bibliographical references (leaves 156-176) Also available in print.

Thesis (Ph. D.)--University of Hong Kong, 2008. / Includes bibliographical references (leaves 156-176) Also available online.

Cardiac output, the volume of blood pumped by the heart over time, is a powerful clinical metric used by physicians to assess overall cardiac health and patient well-being. However, current cardiac output estimation methods are typically invasive, time-consuming, expensive, or some combination of all three. Patients that receive artificial cardiac pacemaker devices are particularly susceptible to cardiac dysfunction and often require long-term cardiac monitoring support. This thesis proposes a novel cardiac output monitoring solution which leverages an implantable intracardiac medical device. The principles of traditional impedance cardiography, an established cardiac output monitoring technique in practice for over fifty years, have been adapted to incorporate a leadless artificial cardiac pacemaker, an implantable medical device contained entirely within the heart. This novel method, colloquially referred to as Z-Cardio, monitors time-varying intracardiac impedance modulation to assess changes in cardiac output. In this study, technologies both old and new are synthesized to produce a novel and effective method of monitoring a critical metric of cardiac health.